The race by companies to sidestep U.S. taxes reached a fever pitch as two drug firms unveiled foreign mergers that will help them slash their tax rates.

The moves—by Illinois-based AbbVie Inc. and Pennsylvania-based Mylan Inc.—show how U.S. drug makers fear being at a disadvantage if they don't find a foreign merger partner to help ease their...

RELATED VIDEO

How Inversion Deals Help Drug Makers Save on Taxes

Drug companies and medical device makers are making multi-billion-dollar merger deals to avoid high U.S. corporate taxes. How do so-called "inversion deals" work? WSJ's Jason Bellini has The Short Answer.